MKI67 and neoplasm: In 3 (5.4%) patients, rebiopsy was performed to rule out potential changes in tumor biology; of these, 1 (2%) patient, with a positive [18F]FDG PET/CT evaluation, showed a change in tumor grade that moved from G1 (Ki67 1%) to G3 grading (Ki67 30%).